Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Hum Reprod ; 22(2): 485-94, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17079246

ABSTRACT

BACKGROUND: The objectives of this study were (i) to evaluate whether the combined use of Syto 16 and 7-amino-actinomycin-D (7-AAD) allows the detection of sperm apoptosis and (ii) to describe a new multiparameter flow cytometric method to assess simultaneously sperm concentration (SC), viability and apoptosis as well as leukocyte concentration. METHODS: Semen samples from 68 patients were evaluated according to World Health Organization (WHO) criteria (normal, n=26; abnormal, n=42). The detection of activated caspases before and after betulinic acid (BA) incubation was carried out in 13 semen samples by flow cytometry using fluorescein-labelled inhibitors of caspases (FLICA). A multiparameter flow cytometric analysis was performed in 55 semen samples. Fluorescent microspheres were used to assess SC. Sperm apoptosis was detected by staining sperm with Syto 16 and 7-AAD. Leukocytes were counted using monoclonal anti-CD45. RESULTS: A significant correlation between the percentage of the spermatozoa with low Syto 16 fluorescence and the percentage of spermatozoa containing activated caspases was found (r=0.68, P=0.0106; n=13). After incubation with BA, an increase of the percentage of apoptotic cells was observed in all samples, using both the Syto 16/7-AAD and the caspase activation methods. There was a good correlation between flow cytometry and optical microscopy for sperm (r=0.98, P < 0.0001) and leukocyte counting (r=0.64, P <0.0001). The percentage of apoptotic sperm was inversely correlated with both SC (r=-0.303, P=0.0246) and morphology (r=-0.384, P=0.0050) but not with motility. CONCLUSIONS: The combination of Syto 16/7-AAD provides a sensitive assay to detect sperm apoptosis. The multiparameter flow cytometric method described offers the possibility of a simultaneous, simple, rapid and accurate assessment of several semen parameters.


Subject(s)
Apoptosis/drug effects , Flow Cytometry/methods , Semen/cytology , Semen/physiology , Adult , Caspases/metabolism , Dactinomycin/analogs & derivatives , Enzyme Activation , Fluorescent Dyes , Humans , Leukocyte Common Antigens/immunology , Leukocytes/cytology , Male , Necrosis , Pentacyclic Triterpenes , Reproducibility of Results , Spermatozoa/drug effects , Triterpenes/pharmacology , Betulinic Acid
2.
Hum Reprod ; 19(4): 838-48, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15016779

ABSTRACT

BACKGROUND: It has recently been suggested that recombinant FSH administration may result in an increased risk of venous thrombosis. An open-label, randomized, controlled trial was carried out to compare the impact of urinary and recombinant FSH on haemostasis. METHODS: Fifty infertile women were randomized, using a random number generator on a personal computer, to receive either highly purified urinary FSH (u-hFSH) or recombinant human FSH (r-hFSH); a starting dose of 150 IU. Human chorionic gonadotrophin 10000 IU was administered once there was at least one follicle > or =18 mm. The luteal phase was supported with progesterone 50 mg/day for at least 15 days. Fifty normally menstruating women were recruited as controls. Repeated measurements of estradiol, progesterone, prothrombin time (PT) expressed as INR, activated partial thromboplastin time (APTT) ratio, fibrinogen (FBG), factor VIII (FVIII), normalized activated protein C ratio (nAPC ratio), antithrombin III activity (AT), protein C activity (PC), protein S activity (PS), tissue-type plasminogen activator antigen (t-PA), type 1 plasminogen activator inhibitor (PAI), prothrombin fragments 1+2 (F1+2), were performed during both hyperstimulated and natural cycles, and at onset of the following menstruation or at 8 weeks of pregnancy. RESULTS: At the end of gonadotrophin administration PT INR increased in the u-hFSH group, while AT and t-PA significantly decreased. In the patients treated with r-hFSH, only F1+2 significantly decreased. No significant changes were observed in the control group. In the luteal phase FBG increased significantly in all groups. In the u-hFSH group no other significant changes were noted compared to pre-ovulatory values, while compared to baseline values AT, PS and t-PA significantly decreased. In the r-hFSH group during the luteal phase PT INR significantly decreased, but did not differ from baseline levels. Other parameters such as FBG, FVIII, t-PA, rose significantly, but only FVIII and FBG values were significantly higher than baseline levels. In the women who became pregnant a significant increase in t-PA and a significant decrease in PS at the midluteal phase were observed. After one month all the haemostatic parameters returned to baseline value if pregnancy failed to occur, while in the pregnant women a significant increase in FVIII and a significant decrease in PS were observed. CONCLUSIONS: Ovarian stimulation with recombinant FSH does not influence coagulation and fibrinolysis significantly, as already reported for urinary gonadotrophins. The moderate changes induced by both treatments are no longer detectable after 4 weeks.


Subject(s)
Follicle Stimulating Hormone, Human/therapeutic use , Hemostasis/drug effects , Infertility, Female/blood , Infertility, Female/drug therapy , Adult , Antithrombin III/metabolism , Estradiol/blood , Factor VIII/metabolism , Female , Fibrinogen/metabolism , Follicle Stimulating Hormone, Human/urine , Humans , Luteal Phase/blood , Ovulation Induction/methods , Peptide Fragments/blood , Pregnancy/blood , Progesterone/blood , Protein Precursors/blood , Protein S/metabolism , Prothrombin , Prothrombin Time , Recombinant Proteins/therapeutic use , Tissue Plasminogen Activator/blood
3.
Hum Reprod ; 17(10): 2665-72, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12351546

ABSTRACT

BACKGROUND: Apoptosis plays an important role in regulating spermatogenesis. However, the biological significance of apoptosis in ejaculated sperm is not yet clear. This study set out to investigate how apoptosis correlates with semen quality and the presence of seminal leukocytes. METHODS: Fifty-seven semen samples from the male partners of infertile couples were classified as normal or abnormal according to World Health Organization guidelines. Flow cytometry was used to evaluate sperm populations and seminal leukocytes. Preliminary flow cytometry analysis using 6-carboxyfluoresceindiacetate (6-CFDA), which identifies live cells, and propidium iodide (PI), which stains only dead cells, was performed in order to pinpoint the sperm region accurately. Having thus gated the sperm population, bivariate Annexin V/PI analysis was then carried out in order to measure the percentage of apoptotic and necrotic sperm and the apoptotic index (the ratio between apoptotic:live sperm). Leukocytes were counted by the standard peroxidase test and by flow cytometry using monoclonal antibody (mAb) anti-CD45 or anti-CD53. RESULTS: No significant differences in the apoptotic index and the percentage of live and apoptotic sperm were detected between the subjects with normal and abnormal semen. A significant inverse correlation between sperm concentration and the apoptotic index was observed only in the normal sperm group. There was no correlation between the concentration of leukocytes, detected either by peroxidase or by mAb anti-CD45 or anti-CD53, either with the percentage of apoptotic sperm or with the apoptotic index. In contrast, the ratio between CD45 positive leukocytes and sperm showed a significant correlation with the apoptotic index. A weaker correlation was found when leukocytes were counted by peroxidase, while no correlation was observed using mAb anti-CD53. CONCLUSIONS: Sperm apoptosis did not seem to be correlated with semen quality. In the absence of genito-urinary infection, one of the main functions of seminal leukocytes is probably to provide for the removal of apoptotic sperm.


Subject(s)
Apoptosis , Leukocytes , Semen/cytology , Semen/physiology , Spermatozoa/cytology , Adult , Annexin A5 , Antibodies, Monoclonal , Antigens, CD/analysis , Antigens, Differentiation, T-Lymphocyte/analysis , Flow Cytometry , Fluoresceins , Fluorescent Dyes , Humans , Leukocyte Common Antigens/analysis , Leukocyte Count , Leukocytes/immunology , Male , Propidium , Spermatozoa/physiology , Tetraspanin 25
4.
Fertil Steril ; 76(6): 1242-8, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11730758

ABSTRACT

OBJECTIVE: To evaluate the efficacy of fallopian sperm perfusion (FSP) using a new method similar to the FAST system in comparison with standard intrauterine insemination (IUI) in patients with unexplained infertility. DESIGN: Prospective, randomized, controlled study. SETTING: Assisted conception service in a University Hospital. PATIENT(S): Women with unexplained infertility undergoing controlled ovarian hyperstimulation (COH). INTERVENTION(S): After hCG administration, patients were randomized to either standard IUI or FSP. The women received the same treatment in the first and all subsequent cycles. A maximum of three cycles was performed. Intrauterine insemination was performed using a standard method, and fallopian sperm perfusion was performed using a commercial device for hysterosalpingography and tubal hydropertubation. MAIN OUTCOME MEASURE(S): Clinical and ongoing pregnancy rates. RESULT(S): A total of 132 cycles was completed: 66 IUI cycles and 66 FSP cycles. In the IUI group, there were 5 ongoing pregnancies, giving a pregnancy rate of 7.6 per cycle and 15.6% per patient; in the FSP group, 14 ongoing pregnancies occurred, giving a pregnancy rate of 21.2% per cycle and 42.4% per patient. The prevalence of multiple pregnancies, miscarriages and ectopic pregnancies was similar in the two insemination groups. Fallopian sperm perfusion was easy to perform, and no case of sperm reflux was observed. The procedure was well tolerated and no complications were observed. The costs were comparable with standard IUI. CONCLUSION(S): In the treatment of couples with unexplained infertility, the method for fallopian sperm perfusion described yields higher pregnancy rates than IUI, with no significant increase in costs or complications. However, these results need to be confirmed in larger studies before replacing IUI with FSP as standard practice.


Subject(s)
Infertility/therapy , Insemination, Artificial/instrumentation , Adult , Chorionic Gonadotropin/blood , Estradiol/blood , Fallopian Tubes/physiology , Female , Humans , Insemination, Artificial/economics , Insemination, Artificial/methods , Male , Pregnancy , Prospective Studies
5.
Gynecol Obstet Invest ; 51(4): 266-70, 2001.
Article in English | MEDLINE | ID: mdl-11408739

ABSTRACT

Vaginal bromocriptine has proven safe and effective in treating hyperprolactinemic women. However, there has been no long-term clinical assessment regarding the influence of daily vaginal bromocriptine administration on the ability to conceive. This article presents two cases of successful pregnancy resulting from this alternative treatment. An infertile woman with an empty sella and hyperprolactinemia was treated with vaginal bromocriptine because of intolerance to oral administration. Prolactin levels were quickly normalized and no side effects occurred. Repeated postcoital tests during treatment proved normal. Twelve months later, the patient conceived. The therapy was discontinued during pregnancy, without complications. Although bromocriptine treatment was not resumed after delivery, postpartum prolactin levels were lower than before treatment and magnetic resonance imaging revealed an unchanged empty sella. Another patient with infertility and pituitary microadenoma with intolerance to oral dopaminergic agonists received the same treatment. Prolactin quickly fell to within the normal range. Vaginal bromocriptine was well tolerated and postcoital test results were not impaired. Tumor regression occurred and 10 months later the patient conceived. Despite bromocriptine withdrawal, no significant complications occurred during pregnancy. It can therefore be concluded that a couple's fertility does not appear to be significantly affected by the persistent local presence of bromocriptine.


Subject(s)
Bromocriptine/administration & dosage , Hormone Antagonists/administration & dosage , Hyperprolactinemia/drug therapy , Infertility, Female/etiology , Adenoma/drug therapy , Administration, Intravaginal , Adult , Bromocriptine/therapeutic use , Female , Hormone Antagonists/therapeutic use , Humans , Hyperprolactinemia/complications , Infertility, Female/therapy , Pituitary Neoplasms/drug therapy , Pregnancy
7.
Surg Gynecol Obstet ; 158(1): 76-80, 1984 Jan.
Article in English | MEDLINE | ID: mdl-6691168

ABSTRACT

In this study, a series of 705 patients with chronic cholecystitis and 203 with acute cholecystitis were surgically treated. The age distribution for the two groups was similar. Operative cholangiography was performed upon 661 patients (94.0 per cent) with chronic cholecystitis and upon 182 patients (90 per cent) with acute cholecystitis. The common bile duct was explored in 146 patients (20.7 per cent) with chronic cholecystitis and in 41 patients (20.1 per cent) with acute cholecystitis, and bile duct calculi were found in 106 patients (15 per cent) with chronic cholecystitis and in 29 patients (14.2 per cent) with acute inflammation of the gallbladder. The total number of postoperative complications and the operative mortality were similar for the two groups. It is concluded that the incidence of common bile duct stones in patients with acute cholecystitis is the same as for those with chronic cholecystitis.


Subject(s)
Cholecystectomy , Cholecystitis/complications , Gallstones/complications , Adolescent , Adult , Aged , Cholecystitis/surgery , Common Bile Duct/surgery , Duodenum/surgery , Female , Gallstones/surgery , Humans , Male , Middle Aged , Postoperative Complications
8.
Rev. Col. Bras. Cir ; 10(6): 187-90, 1983.
Article in Portuguese | LILACS | ID: lil-19166

ABSTRACT

Trinta pacientes com adenocarcinoma primario dos ductos biliares extra-hepaticos foram tratados no Hospital de Clinicas N.S. das Gracas de Curitiba entre 1975 e 1982. Esta neoplasia e rara e incide mais frequentemente em homens e na setima decada da vida. As caracteristicas clinicas principais foram ictericia, perda de peso e dor abdominal. A colangiografia transparieto-hepatica e a colangiopancreatografia endoscopica retrograda foram os exames diagnosticos pre-operatorios mais importantes. Resseccao curativa da neoplasia foi realizada em somente dois pacientes que nao apresentavam metastases ou invasao das estruturas vizinhas. Em 16 doentes foi realizada somente biopsia dos tumores e em nove, operacoes paliativas. A mortalidade operatoria deste carcinoma e elevada e o prognostico ruim


Subject(s)
Adult , Middle Aged , Humans , Male , Female , Adenocarcinoma , Bile Duct Neoplasms , Cholestasis, Extrahepatic
SELECTION OF CITATIONS
SEARCH DETAIL
...